CTOs on the Move

Solid Biosciences

www.solidbio.com

 
Solid Biosciences (Solid) is a life science company singularly focused on solving Duchenne muscular dystrophy (Duchenne). We aim to be the center of excellence across the entire disease spectrum, serving as a catalyst to bring together those with the expertise in science, technology, disease management and care. Disease-focused and founded by a family directly impacted, our mandate is simple yet comprehensive - attack the roots of the disease and improve daily life for patients. Solid is headquartered in Cambridge, MA, USA.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.solidbio.com
  • 141 Portland Street Fifth Floor
    Cambridge, MA USA 02139
  • Phone: 617.337.4680

Executives

Name Title Contact Details
Keith Clark
Senior Director Information Technology Profile
Keith Clark
Associate Director, Information Technology Profile

Funding

Solid Biosciences raised $42.5M on 11/03/2015
Solid Biosciences raised $50M on 03/30/2017
Solid Biosciences raised $40M on 10/23/2020
Solid Biosciences raised $90M on 12/11/2020
Solid Biosciences raised $143.8M on 03/21/2021

Similar Companies

OncoArendi Therapeutics

OncoArendi Therapeutics SA (WSE:OAT) is a Polish innovative biotechnology company specializing in research, development and commercialization of innovative small molecule drugs for treatment of respiratory diseases and cancer.

Future Family

Future Family is where women, men and couples start their fertility journey. The company`s mission is to make fertility care accessible and affordable to all.

Uromedica

Uromedica is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nautilus Environmental

Nautilus Environmental is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioAmber

BioAmber is a renewable chemistry company. We use agricultural crops and transform them into green chemicals that directly substitute chemicals derived from oil. BioAmber combines industrial biotechnology and chemical catalysis into a process that offers a better carbon footprint than petrochemicals. In addition to moving away from petroleum, our process consumes CO2, directly reducing greenhouse gas emissions and aiding in the fight against global warming. Bioamber is today the only producer of bio-succinic acid, a chemical building block used in a number of applications, such as plastics, polyurethane, solvents, personal care, plasticisers, etc.